Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Better Biotech
  4.  » 
  5. Biologics
  6.  » Q&A with Industry Veteran Jim Spavins
Icon of a document with a pencil

Q&A with Industry Veteran Jim Spavins

Summary: In nearly 40 years at Pfizer and in consulting, Spavins has helped many scientists make the jump from academic approaches to the needs of the boardroom. We sat down with Jim, a board member of the Catalent Applied Drug Delivery Institute, to discuss what founders must consider when launching a biotech startup, how to navigate complex regulatory and funding challenges, and the benefits of partnering with trusted contract development and manufacturing organizations (CDMOs) like Catalent.

Download Article